ORLANDO, Fla. – Advisers to the Centers for Disease Control and Prevention are meeting to discuss the risks and benefits of the Johnson & Johnson vaccine following its pause in use because of several severe clot cases in the U.S.
Six women developed extreme clotting after receiving the J&J vaccine, with one 18-year-old woman receiving three brain surgeries related to the clots, according to the Associated Press.
The advisers to the CDC met last week to discuss the vaccine and decided further evidence was needed before moving forward with a decision on use. [TRENDING: SpaceX launches 4 astronauts into space | What were those white flashes in sky after Crew-2 launch? | 2 killed when car splits in half in crash with train] The advisers are